Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Airflow Limitation in Stable Asthmatics
NCT01225913Phase 4Recruiting
- Start
- Oct 2007
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of salmeterol + fluticasone and budesonide + formoterol in asthma. Primary endpoint: Exhaled nitric oxide. Started Oct 2007; status: recruiting.
02
Drugs
salmeterol + fluticasonebudesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01225913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225913.